Skip to main content
SpringerLink
Log in

Outline of Surgery (Refer to Hysterectomy in Section of Cervical Cancer)

  • Chapter
  • First Online:
Book cover Surgery for Gynecologic Cancer

Part of the book series: Comprehensive Gynecology and Obstetrics ((CGO))

  • 669 Accesses

Abstract

Surgery is usually the principal treatment for endometrial cancer and includes hysterectomy, often along with salpingo-oophorectomy and lymph node dissection. Acquisition of pelvic washing samples is preferable. In some cases, the omentum is removed and/or peritoneal biopsies are obtained. If the cancer has spread throughout the pelvis and abdomen, as much cancer as possible should be removed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

    Article  Google Scholar 

  2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. 1997;47:5–27.

    Article  CAS  Google Scholar 

  3. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the corpus uteri FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95:S105–43.

    Article  Google Scholar 

  4. Signorelli M, Lissoni AA, Cormio G, Katsaros D, Pellegrino A, Selvaggi L, Ghezzi F, Scambia G, Zola P, Grassi R, Milani R, Giannice R, Caspani G, Mangioni C, Floriani I, Rulli E, Fossati R. Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study. Ann Surg Oncol. 2009;16:3431–41.

    Article  Google Scholar 

  5. Han CH, Lee KH, Lee HN, Kim CJ, Park TC, Park JS. Does the type of hysterectomy affect the prognosis in clinical stage I endometrial cancer? J Obstet Gynecol Res. 2010;36:581–7.

    Article  Google Scholar 

  6. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984;63:825–32.

    CAS  PubMed  Google Scholar 

  7. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035–41.

    Article  CAS  Google Scholar 

  8. Boente MP, Yordan EL Jr, McIntosh DG, Grendys EC Jr, Orandi YA, Davies S, Beck D, Graham JE Jr, Miller A, Marshall R, et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol. 1993;51:316–22.

    Article  CAS  Google Scholar 

  9. Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K. Ovarian metastasis in endometrial carcinoma. Gynecol Oncol. 1998;70:183–7.

    Article  CAS  Google Scholar 

  10. Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1999;181:31–4.

    Article  CAS  Google Scholar 

  11. Sakuragi N, Hareyama H, Todo Y, Yamada H, Yamamoto R, Fujino T, Sagawa T, Fujimoto S. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand. 2000;79:311–6.

    Article  CAS  Google Scholar 

  12. Michelesen TM, Pripp AH, Tonstad S, Trope CG, Dorum A. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer. 2009;45:82–9.

    Article  Google Scholar 

  13. Dorum A, Tonstad S, Liavaag AH, Michelesen TM, Hildrum B, Dahl AA. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol. 2008;109:377–83.

    Article  Google Scholar 

  14. Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009;27:1214–9.

    Article  Google Scholar 

  15. Koskas M, Bendifallah S, Luton D, Daraï E, Rouzier R. Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery. Fertil Steril. 2012;98:1229–35.

    Article  Google Scholar 

  16. Lee TS, Lee JY, Kim JW, Oh S, Seong SJ, Lee JM, Kim TJ, Cho CH, Kim SM, Park CY. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study. Gynecol Oncol. 2013;131:289–93.

    Article  Google Scholar 

  17. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol. 1998;91:349–54.

    Article  CAS  Google Scholar 

  18. Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol. 1995;85:504–8.

    Article  CAS  Google Scholar 

  19. Wethington SL, Barrena Medel NI, Wright JD, Herzog TJ. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery. Gynecol Oncol. 2009;115:18–25.

    Article  Google Scholar 

  20. Hirai Y, Fujimoto I, Yamauchi K, Hasumi K, Masubuchi K, Sano Y. Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma. Obstet Gynecol. 1989;73:335–8.

    CAS  PubMed  Google Scholar 

  21. Ebina Y, Hareyama H, Sakuragh N, Yamamoto R, Furuya M, Sogame M, Fujino T, Makinoda S, Fujimoto S. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg. 1997;82:244–8.

    CAS  PubMed  Google Scholar 

  22. Takeshima N, Nishida H, Tabata T, Hirai Y, Hasumi K. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol. 2001;82:470–3.

    Article  CAS  Google Scholar 

  23. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002;86:38–44.

    Article  Google Scholar 

  24. Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, Ohmi K, Sasajima Y, Matsuno Y. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer. 2003;88:245–50.

    Article  CAS  Google Scholar 

  25. Tebeu PM, Popowski Y, Verkooijen HM, Bouchardy C, Ludicke F, Usel M, Major AL. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. Br J Cancer. 2004;91:720–4.

    Article  Google Scholar 

  26. Turner DA, Gershenson DM, Atkinson N, Sneige N, Wharton AT. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol. 1989;74:775–80.

    CAS  PubMed  Google Scholar 

  27. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 1991;78:63–9.

    CAS  PubMed  Google Scholar 

  28. Kashimura M, Sugihara K, Toki N, Matsuura Y, Kawagoe T, Kamura T, Kaku T, Tsuruchi N, Nakashima H, Sakai H. The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol. 1997;67:285–90.

    Article  CAS  Google Scholar 

  29. Obermair A, Geramou M, Tripcony L, Nicklin JL, Perrin L, Crandon AJ. Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett. 2001;164:105–10.

    Article  CAS  Google Scholar 

  30. Saga Y, Imai M, Jobo T, Kuramoto H, Takahashi K, Konno R, Ohwada M, Suzuki M. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol. 2006;103:277–80.

    Article  Google Scholar 

  31. Havrilesky LJ, Cragun JM, Calingaert B, Alvarez Secord A, Valea FA, Clarke-Pearson DL, Berchuck A, Soper JT. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007;104:401–5.

    Article  Google Scholar 

  32. Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet. 2009;105:110–1.

    Article  Google Scholar 

  33. Shiozaki T, Tabata T, Yamada T, Yamamoto Y, Yamawaki T, Ikeda T. Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature. Int J Gynecol Cancer. 2014;24:549–55.

    Article  Google Scholar 

  34. Milgrom SA, Kollmeier MA, Abu-Rustum NR, Makker V, Gardner GJ, Barakat RR, Alektiar KM. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecol Oncol. 2013;130:49–53.

    Article  CAS  Google Scholar 

  35. Garg G, Gao F, Wright JD, Hagemann AR, Mutch DG, Powell MA. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer. Gynecol Oncol. 2013;128:77–82.

    Article  Google Scholar 

  36. Chen SS, Spiegel G. Stage I endometrial carcinoma. Role of omental biopsy and omentectomy. J Reprod Med. 1991;36:627–9.

    CAS  PubMed  Google Scholar 

  37. Saygili U, Kavaz S, Altunyurt S, Uslu T, Koyuncuoglu M, Erten O. Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma. Int J Gynecol Cancer. 2001;11:471–4.

    Article  CAS  Google Scholar 

  38. Dilek S, Dilek U, Dede M, Deveci MS, Yenen MC. The role of omentectomy and appendectomy during the surgical staging of clinical stage I endometrial cancer. Int J Gynecol Cancer. 2006;16:795–8.

    Article  CAS  Google Scholar 

  39. Fujiwara H, Saga Y, Takahashi K, Ohwada M, Enomoto A, Konno R, Tanaka A, Suzuki M. Omental metastases in clinical stage I endometrioid adenocarcinoma. Int J Gynecol Cancer. 2008;18:165–7.

    Article  CAS  Google Scholar 

  40. Metindir J, Dilek GB. The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma. J Cancer Res Clin Oncol. 2008;134:1067–70.

    Article  Google Scholar 

  41. Ozdal B, Unlu BS, Yalcin HR, Tapisiz OL, Energin H, Besli M, Gungor T. Role of omentectomy and appendectomy in surgical staging of endometrioid endometrial cancer. Eur J Gynaecol Oncol. 2013;34:322–4.

    CAS  PubMed  Google Scholar 

  42. Ulker V, Tunca A, Numanoglu C, Akbayir O, Akyol A, Erim A, Ongut C. Should omentectomy be a part of surgical staging in patients with endometrioid adenocarcinoma of the uterine corpus? Gynecol Obstet Investig. 2014;77:58–63.

    Article  CAS  Google Scholar 

  43. Sakai K, Yamagami W, Susumu N, Nomura H, Kataoka F, Banno K, Tsuda H, Aoki D. Pathological factors associated with omental metastases in endometrial cancer. Eur J Gynaecol Oncol. 2015;36:397–401.

    CAS  PubMed  Google Scholar 

  44. Joo WD, Schwartz PE, Rutherford TJ, Seong SJ, Ku J, Park H, Jung SG, Choi MC, Lee C. Microscopic omental metastasis in clinical stage I endometrial cancer: a meta-analysis. Ann Surg Oncol. 2015;22:3695–700.

    Article  Google Scholar 

  45. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and para-aortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996;62:169–73.

    Article  CAS  Google Scholar 

  46. Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, Yaegashi N. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 2004;92:669–74.

    Article  Google Scholar 

  47. Larson DM, Johnson KK. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium. Gynecol Oncol. 1993;51:345–8.

    Article  CAS  Google Scholar 

  48. Fanning J, Nanavati PJ, Hilgers RD. Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors. Obstet Gynecol. 1996;87:1041–4.

    Article  CAS  Google Scholar 

  49. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol. 1997;64:411–7.

    Article  CAS  Google Scholar 

  50. Lee KB, Ki KD, Lee JM, Lee JK, Kim JW, Cho CH, et al. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study. Ann Surg Oncol. 2009;16:2882–7.

    Article  Google Scholar 

  51. Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, Soslow RA, Dao F, Sonoda Y, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009;113:163–9.

    Article  Google Scholar 

  52. Chiang AJ, Yu KJ, Chao KC, Teng NN. The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. Gynecol Oncol. 2011;121:122–5.

    Article  Google Scholar 

  53. Solmaz U, Mat E, Dereli ML, Turan V, Tosun G, Dogan A, et al. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2015;186:63–7.

    Article  Google Scholar 

  54. Chen SS, Lee L. Retroperitoneal lymph node metastases in Stage I carcinoma of the endometrium: correlation with risk factors. Gynecol Oncol. 1983;16:319–25.

    Article  CAS  Google Scholar 

  55. Ayhan A, Tuncer ZS, Tuncer R, Yüce K, Küçükali T. Tumor status of lymph nodes in early endometrial cancer in relation to lymph node size. Eur J Obstet Gynecol Reprod Biol. 1995;60:61–3.

    Article  CAS  Google Scholar 

  56. Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol. 1997;65:82–7.

    Article  CAS  Google Scholar 

  57. Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL. Gynecologic Oncology Group. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol. 2012;119:286–92.

    Article  Google Scholar 

  58. Sueoka K, Umayahara K, Abe A, Usami T, Yamamoto A, Nomura H, et al. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Int J Gynecol Cancer. 2015;25:81–6.

    Article  Google Scholar 

  59. Mahdi H, Jernigan A, Nutter B, Michener C, Rose PG. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion. J Gynecol Oncol. 2015;26:208–13.

    Article  CAS  Google Scholar 

  60. Onda T, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer. 1997;75:1836–41.

    Article  CAS  Google Scholar 

  61. Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, et al. Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. Cancer Lett. 2002;180:83–9.

    Article  CAS  Google Scholar 

  62. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109:11–8.

    Article  Google Scholar 

  63. Fujimoto T, Nanjyo H, Fukuda J, Nakamura A, Mizunuma H, Yaegashi N, et al. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecol Oncol. 2009;112:342–7.

    Article  Google Scholar 

  64. Dogan NU, Gungor T, Karsli F, Ozgu E, Besli M. To what extent should para-aortic lymphadenectomy be carried out for surgically staged endometrial cancer? Int J Gynecol Cancer. 2012;22:607–10.

    Article  Google Scholar 

  65. Odagiri T, Watari H, Kato T, Mitamura T, Hosaka M, Sudo S, et al. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials. Ann Surg Oncol. 2014;21:2755–61.

    Article  Google Scholar 

  66. Altay A, Toptas T, Dogan S, Simsek T, Pestereli E. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination. Int J Gynecol Cancer. 2015;25:657–64.

    Article  Google Scholar 

  67. Tomisato S, Yamagami W, Susumu N, Kuwahata M, Takigawa A, Nomura H, et al. Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer. J Obstet Gynaecol Res. 2014;40:1733–9.

    Article  Google Scholar 

  68. Fotopoulou C, El-Balat A, du Bois A, Sehouli J, Harter P, Muallem MZ, et al. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer. Arch Gynecol Obstet. 2015;292:1321–7.

    Article  CAS  Google Scholar 

  69. Sautua RR, Goiri K, Calle MA, Marin IJ, Artola AL. Incidence of nodal metastasis and isolated aortic metastases in patients with surgically staged endometrioid endometrial cancer. Int J Gynecol Cancer. 2015;25:875–8.

    Article  Google Scholar 

  70. Alay I, Turan T, Ureyen I, Karalok A, Tasci T, Ozfuttu A, et al. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer. Pathol Oncol Res. 2015;21:803–10.

    Article  Google Scholar 

  71. Todo Y, Suzuki Y, Azuma M, et al. Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer. Gynecol Oncol. 2012;127:532–7.

    Article  Google Scholar 

  72. Wright JD, Lewin SN, Barrena Medel NI, Sun X, Burke WM, Deutsch I, Herzog TJ. Morbidity and mortality of surgery for endometrial cancer in the oldest old. Am J Obstet Gynecol. 2011;205:66.e1–8.

    Article  Google Scholar 

  73. Chi DS, Welshinger M, Venkatraman ES, Barakat RR. The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol. 1997;67:56–60.

    Article  CAS  Google Scholar 

  74. Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Montz FJ. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol. 2000;78:85–91.

    Article  CAS  Google Scholar 

  75. Ayhan A, Taskiran C, Celik C, Yuce K, Kucukali T. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int J Gynecol Cancer. 2002;12:448–53.

    Article  CAS  Google Scholar 

  76. Ueda Y, Enomoto T, Miyatake T, Egawa-Takata T, Ugaki H, Yoshino K, Fujita M, Kimura T. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery. Ann Surg Oncol. 2010;17:1111–7.

    Article  Google Scholar 

  77. Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, Karlan BY, Berek JS, Farias-Eisner R. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Int J Gynecol Cancer. 2002;12:454–8.

    Article  CAS  Google Scholar 

  78. Thomas MB, Mariani A, Cliby WA, Keeney GL, Podratz KC, Dowdy SC. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol. 2007;107:190–3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan

    Yukiharu Todo

Authors
  1. Yukiharu Todo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yukiharu Todo .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, School of Medicine, Tokai University, Isehara, Japan

    Mikio Mikami

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Todo, Y. (2019). Outline of Surgery (Refer to Hysterectomy in Section of Cervical Cancer). In: Mikami, M. (eds) Surgery for Gynecologic Cancer. Comprehensive Gynecology and Obstetrics. Springer, Singapore. https://doi.org/10.1007/978-981-13-1519-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1519-0_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-1518-3

  • Online ISBN: 978-981-13-1519-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation